48993-24-V1-RES-trinity-landingpage-static-banner-0626.png

Put PLATINUM Blades to the test for 30 days

With efficient resection, less clogging than competitor devices and a low risk of metal debris,**4,5 we’re confident our flagship blade technology will meet your expectations. In fact, we’re so confident in our PLATINUM Blades we offer a 30-day satisfaction guarantee in the US.

With the PLATINUM Handpiece, try the perfect pairing for premium performance.

(Return the unused portion of the PLATINUM Blade order for a credit. Credit and return goods authorization must be requested within 30 days of purchase.)

PLATINUM-LIBE-webpage-rosette-badge-0624

FLOW FLEXTEND Wand key features

  • Builds on our hip wand innovation to provide increased access with intuitive simplicity.1
  •  Adjustable angle from -10 to +65 with intuitive markers and hands-free retention of desired angle.1,2
  •  Tapered tip has been engineered for optimal tissue targeting, even in hard-to-reach hip anatomy.3
  •  Removes tissue with precision and efficiency (shown in benchtop testing), automatically regulating saline outflow with COBLATION energy.2,6,7
  • Uses FLOW~IQ Technology, demonstrated ex vivo to remove free-floating tissue approximately four times faster than non-FLOW~IQ wands.***8
  • Provides accurate, real-time temperature monitoring of intra-articular fluid using AMBIENT Technology.2,9,10
FLOW FLEXTEND static graphic

INTELLIO SHIFT System key features

  • Streamline your OR with the ability to control two resection methods in one powerful solution
  • Shift seamlessly between mechanical resection and COBLATION Technology radiofrequency (RF) tissue removal11-14
  • Use an intuitive touchscreen or integrated foot pedal for uninterrupted control,12-14 letting you keep your focus on your work
  • Full connectivity to a range of COBLATION Wands and DYONICS Blades
  • Customizable user profiles for a consistent experience, with the option for a default facility profile14
  • Short learning curve for novice users12

FLOW 50 Wand key features

  • Resection performance in knee arthroscopy indications
  • Suitable for multiple joint soft tissue types11,15-18
  • Currently the only wand indicated for cartilage resection
  • Profiled, angled shaft is designed to target knee anatomy19-21
  • Creates a smooth articular surface22
  • Controlled plasma field and precise tissue removal have been shown to minimize damage to surrounding tissue****6
Hero 1_COBLATION_FLOW_50_Wand_791101.png

FLOW 90 Wand key features

  • Engineered to tackle complex shoulder arthroscopy indications
  • Significantly faster ablation than other frequently-used 90° wands*****23
  • Uses FLOW~IQ Technology to change the plasma field’s size/intensity for the desired tissue effect across shoulder pathologies
  • Innovative triangular tip design facilitates tissue manipulation
  • Integrated suction tubing eliminates the costs associated with separate tubing lines
  • Fits down a 5mm cannula
Hero 1_COB18_Flow90_Tip_Top_14288.png

30 years of COBLATION Technology

Sports medicine resection was very different in the mid-1990s. Tools such as electrocautery performed a task at the time, but their reliance on heat-driven methods came with notable drawbacks in the form of thermal damage, a narrow margin of error around delicate anatomy, and adverse effects on patient healing.

A breakthrough concept of passing a radiofrequency current through saline emerged, allowing engineers to generate a low-temperature plasma field capable of disassociating tissue on a molecular level using energized ions rather than thermal destruction.

The resulting ‘controlled ablation’ (or COBLATION) entered the field of sports medicine in 1996 and offered surgeons a true alternative that redefined the standards for resection.

Continuing to evolve over three decades of research and innovation, including refined wand designs, improved delivery systems and expanded indications, COBLATION Technology continues to set the gold standard for resection.

Disclaimers

*Compared to HipVac and FLOW 50.

**Less clogging than competitor devices - n=30; as demonstrated ex vivo at maximum settings. Low risk of metal debris - as demonstrated in bench-top testing and cadaveric studies.

***In Vac mode. As demonstrated ex vivo with Ambient Super MultiVac 50, FLOW 50, FLOW 90 and FLOW FLEXTEND wands.

****Minimal damage (100-200μm) evident in untargeted cartilage tissue, as demonstrated ex vivo. Cell damage may vary depending on protocol use.

*****As demonstrated in vitro when tested at default settings; p<0.05.

Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area. For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.

 

 

Citations
  1. Smith+Nephew 2026. Internal Report. P/N 10171095.
  2. Smith+Nephew 2025. Internal Report. P/N 10155104_B.
  3. Smith+Nephew 2026. Internal Report. P/N 10171298_A.
  4. Smith + Nephew 2019 Internal report. 15007992 Rev A.
  5. Smith+Nephew 2021. Internal report. E0.SPM.PCS031.003.v1.
  6. Amiel, D et al. Arthroscopy, 2004;20(5):503-510.
  7. Smith+Nephew 2020. Internal Report. P/N SPMENT-88067-02_A.
  8. Smith and Nephew 2026. Internal Report. P/N 10171132_A.
  9. Smith and Nephew 2026. Internal Report. P/N 10171562_A.
  10. Smith and Nephew 2026. Internal Report. P/N 10171150_A.
  11. Chivot M, et al. Eur J Orthop Surg Traumatol, 2019;29(6):1205-1210.
  12. Smith+Nephew 2023. Internal Report. P/N 10092266 Rev. A.
  13. Smith+Nephew 2023. Internal Report. 100914436 Rev. A.
  14. Smith+Nephew 2023. Internal Report. P/N 10092118 Rev. A.
  15. Gharaibeh M, et al. Cartilage. 2018;9(3):241-247.
  16. Liu YJ, et al. Clin Orthop Relat Res. 2009;467(3):799-804.
  17. Sean NY, et al. Foot Ankle Surg. 2010;16(4):174-177.
  18. Taverna E, et al. Arthroscopy. 2007;23(10):1042-1051.
  19. ArthroCare 2014. Internal report. P/N 48261_01_A.
  20. ArthroCare 2017. Internal report. P/N 92306_01_B.
  21. ArthroCare 2015. Internal report. P/N 65200_01_A.
  22. ArthroCare 2014. Internal report. P/N 54950_01_A.
  23. Smith+Nephew 2020. Internal report. P/N 112090 Rev. A.

Title

Text